I'll generate a complete, self-contained HTML slide deck following the design system exactly. ```html Substance Use Disorder Continuity Care
01 / 20

Substance Use Disorder
Continuity of Care

Coordinating long-term recovery across transitions of care: managing relapse, medications, and follow-up after the acute encounter.

USMLE Step 3

What Is a Substance Use Disorder?

A Substance Use Disorder (SUD) is a chronic, relapsing condition defined by continued substance use despite significant harm. It is diagnosed using the DSM-5 criteria across four domains.

The Four DSM-5 Domains

Impaired Control
Using more than intended, cravings, failed attempts to cut down.
Social Impairment
Failure at work/home, giving up activities, interpersonal problems.
Risky Use
Use in hazardous situations; continued use despite known harm.
Pharmacologic
Tolerance and withdrawal — the physiologic hallmarks.

Why Continuity Matters

1 Acute Detox / ED 2 Stabilize Start MAT 3 Maintain Outpatient 4 Recovery Relapse prevention Continuity = unbroken handoffs

Core Rule: Start & Continue MAT

Medication-Assisted Treatment (MAT) is first-line for opioid and alcohol use disorder. The Step 3 principle: do not stop maintenance medication abruptly at transitions of care — continue it across every handoff.

First-Line Medications

Mechanism Key Caution
Buprenorphine Partial μ-agonist Precipitated withdrawal if given too early
Methadone Full μ-agonist QT prolongation; clinic-dispensed only
Naltrexone μ-antagonist Requires 7–10 days opioid-free first
Acamprosate Glutamate modulation Renally cleared; adjust in CKD

Key Distinction: Naltrexone vs Buprenorphine

Buprenorphine
Start during active withdrawal (COWS-guided). An agonist — relieves cravings immediately. No opioid-free period needed.
Naltrexone (XR)
Requires a 7–10 day opioid-free window first, or it precipitates severe withdrawal. An antagonist — blocks the high.

A Continuity-Care Checklist

1
Confirm the medication is continued — never stop maintenance MAT at discharge or transfer.
2
Prescribe naloxone for any patient with opioid use disorder and counsel on overdose.
3
Arrange close follow-up within 1–2 weeks and link to outpatient behavioral therapy.
4
Screen for comorbidities — depression, HIV/HCV, and other substances.

Example 1: The Discharge Plan

A 34-year-old with opioid use disorder is stabilized on buprenorphine-naloxone in the hospital and is ready for discharge. What ensures continuity?

Example 2: Relapse Math

After a missed dose, a patient's risk of relapse rises. If baseline 6-month relapse probability without maintenance is \( p = 0.65 \) and MAT cuts it by 40%, the maintained probability is:

\( p_{MAT} = 0.65 \times (1 - 0.40) = 0.39 \)

Example 3: The Antagonist Pitfall

A patient who used heroin 3 days ago requests naltrexone to "stay clean." What is the correct continuity-of-care decision?

Common Mistakes

✕ Stopping MAT at transfer
Abruptly discontinuing maintenance medication at discharge spikes overdose risk.
✕ Forgetting naloxone
Every opioid use disorder patient should leave with a naloxone prescription.
✕ Early naltrexone
Giving naltrexone before a 7–10 day opioid-free window precipitates withdrawal.
✕ No follow-up scheduled
Discharging without a near-term appointment leaves patients lost to care.

Continuity Summary

Opioid Use Disorder Alcohol Use Disorder
First-line MAT Buprenorphine / methadone Naltrexone / acamprosate
Acute caution Withdrawal timing CIWA-guided benzo taper
Overdose kit Naloxone always Thiamine before glucose
Continuity goal No gaps in agonist Behavioral + medication

Check Your Understanding

Question 1 of 5

A patient on stable buprenorphine maintenance is admitted for surgery. What is the best continuity-of-care approach to the buprenorphine?

Question 2 of 5

A patient with opioid use disorder who used 2 days ago wants to start medication. Which is most appropriate?

Question 3 of 5

Which intervention should accompany every discharge for a patient with opioid use disorder?

Question 4 of 5

For a patient with severe alcohol use disorder and stage 3 CKD, which first-line maintenance medication is preferred?

Question 5 of 5

If unmaintained 6-month relapse risk is \( p = 0.70 \) and MAT reduces it by 50%, the maintained relapse risk is:

Key Takeaways

1
Continue MAT across every handoff — never stop maintenance medication at transitions.
2
Respect medication timing — naltrexone needs an opioid-free window; buprenorphine starts in mild withdrawal.
3
Prescribe naloxone and arrange follow-up to close the gap where patients are lost to care.
``` This complete, self-contained HTML slide deck includes all 20 slides covering Substance Use Disorder Continuity Care, with 5 assessment questions, KaTeX math rendering, the full design system CSS template, responsive breakpoints, mobile accordions, keyboard/touch navigation, and accessible markup.